• Tuberculosis and Respiratory Diseases
• /
• v.54 no.5
• /
• pp.532-541
• /
• 2003

Background : Phospholipase $A_2$ ($PLA_2$) has been known to be involved in the pathogenesis of acute lung injury (ALI) including ARDS. Since doxycycline has the property of inhibiting secretory group II $PLA_2$, the therapeutic effect of doxycycline hyclate was investigated for gut ischemia/reperfusion (I/R)-induced ALI in Sprague-Dawley rats. Methods : ALI was induced in Sprague-Dawley rats by clamping of the superior mesenteric artery for 60 min, followed by 120 min of reperfusion. To confirm the pathogenetic mechanisms of this ALI associated with neutrophilic oxidative stress, we measured bronchoalveolar lavage (BAL) protein content and lung MPO, and performed cyto-chemical electron microscopy for detection of free radicals, assay of $PLA_2$ activity and cytochrome-c reduction assay. Results : In gut I/R-induced ALI rats, protein leakage, pulmonary neutrophil accumulation, free radical production and lung $PLA_2$ activity were all increased. These effects were reversed by doxycycline hyclate. Conclusion : Doxycycline appears to be effective in ameliorating the gut I/R-induced ALI by inhibiting $PLA_2$, thereby decreasing the production of free radicals from neutrophils.

• Journal of The Korean Dental Society of Anesthesiology
• /
• v.8 no.1
• /
• pp.29-34
• /
• 2008

배경: 신경병증성 통증은 스테로이드, 아편유사제 등의 진통제에 잘 반응하지 않는다. 하지만 염증성 매개물질들이 신경병증성 통증의 발생에 관여한다는 보고가 있다. 특히 선택적 COX2 억제제인 celecoxib의 신경병증성 통증에 대한 효과에 관해서 상반된 연구결과가 존재한다. 본 연구는 신경병증성 통증 모델인 척추신경 결찰모델을 이용 기계적, 냉각 이질통 및 온도감각 과민현상의 발현에 celecoxib이 미치는 영향을 관찰하여 celecoxib의 항통각효과를 확인하고자 하였다. 방법: 30마리의 쥐를 이용 척추신경을 결찰하여 신경병증성 통증을 유도하였다 celecoxib (1, 10, 100, and 300 mg/kg)을 경구 투여하였고 총 30마리 중 12마리의 쥐에서 열, 기계적자극에 대해서 통각과민, 냉각자극에 의해 이질통이 발생하였다. 약물 투여 후 30, 60, 120, 180분 후 von Frey, 냉각자극검사, Hargreaves검사를 시행하여 쥐의 행동변화를 관찰하였다. 결과: 신경결찰 후 5일 후에 celecoxib의 용량에 관계없이 열, 기계적 자극에 의한 통각과민, 냉각 자극에 대한 이질통을 감소시키지 않았다(P > 0.05). 또한 celecoxib투여에 의한 장기간의 항 통각효과는 관찰되지 않았다(P > 0.05). 결론: celecoxib을 경구로 투여하였을 때 장기간 유지된 신경병증성 통증 흰쥐에서 약의 투여용량, 투여기간에 따른 항 통각작용은 관찰되지 않았다. 따라서 조직 손상후 발생된 장기간의 신경병증성 통증에 있어서 celecoxib은 효과가 없는 것으로 사료된다.

• Journal of Pharmacopuncture
• /
• v.3 no.1
• /
• pp.35-51
• /
• 2000

The purpose of this study is to prove the analgesic effects of apitoxin and its mechanism via jaw-opening reflex(JOR) and measuring expression of mRNA in Phospholipase and Tryptophan hydroxylase(TPH) using RT-PCR. The experiments were carried out on Sprague-Dawley rats(300-400g) and mastocytoma(P-185 HTR) for JOR and RT-PCR, respectively. Rats anesthetized with thiopental sodium (80mg/kg) were used in the Tooth Pulp stimulation induced JOR. The amplitude of a digastric electromyogram (dEMG) was recorded during the stimulation at an intensity of 1.5 times the threshold for JOR. Apitoxin used in this experiment was diluted with normal saline by 1:1000. Apitoxin was injected intravenously into the test group while normal saline to the control group. However, it was injected directly into the cell of mastocytoma. We referred to base sequence registered in Genbank in designing primers for RT-PCR. The results were as follows; (1)Compared with control group, analgesic effect started to show right after Sprague-Dawely rats were treated with apitoxin($71.50{\pm}8.08$) and lasted for 50 minutes. (2)As a result of the experiment of RT-PCR, we witnessed significant changes in the degree of expression of phospholipase or rate-limiting enzyme of biosynthesis of prostaglandins with $10{\mu}g/ml$ apitoxin.($31.74{\pm}18.98%$, P<0.05) (3)As a result of the experiment of RT-PCR, we witnessed significant changes in the degree of expression of TPH or rate-limiting enzyme in biosynthesis of serotonin with $10{\mu}g/ml$ apitoxin.($131.37{\pm}16.87%$, P<0.05). These results suggest that $10{\mu}g/ml$ apitoxin have the most analgesic effects. This study showed that apitoxin has analgesic effects and held good for 50 minutes. The injection of apitoxin has brought out changes in the degree of expression of phospholipase and TPH. These results strongly suggest that analgesic mechanism by apitoxin is closely related to prostaglandins and serotonin.

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.20 no.4
• /
• pp.825-829
• /
• 2006

Rhus verniciflua Stokes has been used for treatment of blood stasis and abdominal mass in Oriental medicine. Rhus verniciflua Stokes has been experimentally reported to exert antioxidant, antiproliferative, antithrombotic and apoptotic activities. In the present study, the antiangiogenic and in vivo antitumor activities of aqueous extract of processed Rhus verniciflua Stokes (Nexia) by heat were examined to elucidate its anticancer mechanism. Nexia showed weak cytotoxiicty against human umbilical vein endothelial cells (HUVEC) and Lewis lung carcinoma cells (LLC) with IC50 of${\sim}200\;{\mu}g/ml\;and\;>200\;{\mu}g/ml$, respectively. Nexia significantly inhibited the proliferation and migratory activity in vascular endothelial growth factor(VEGF) treated HUVEC. Furthermore, Nexia effectively suppressed the tumor volume in A549 nonsmall lung cancer bearing athymic nude mice, CanN. Cg-Foxn 1nu/CrljBgi up to 40.7% as well as tumor weight incised from LLC cells innoculated into the flank of C57BL/6 mice up to -50% compared with untreated control at a dose of 300 mg/kg. Taken together, these results suggest that processed Rhus verniciflua Stokes may inhibit the growth of Lewis lung carcinoma cells partly via inhibition of angiogenesis and can be potently applied to angiogenesis dependent cancers. However, it still needs a further research on molecular mechanism, angiogenesis animal study and clinical trial in future.

• Proceedings of the Korea Water Resources Association Conference
• /
• 2019.05a
• /
• pp.197-197
• /
• 2019

총인처리시설에서는 응집제를 주입하여 인이나 오염물질을 침전시켜 처리하고 있으며 PAC(poly aluminum chloride)나 $FeCl_3$, $Al_2(SO_4)_3$, 등 다양한 종류의 응집제가 사용되어지고 있다. 하지만 기존에 사용되어 지고 있는 알루미늄계열의 응집제는 처리수에 잔류이온이 존재하게 되어 인체에 축적돼 알츠하이머 병 등 신체질환을 유발할 수 있는 단점이 있다. 따라서 이러한 단점을 사전에 예방하기 위해 $TiCl_4$와 같은 티타늄계열 응집제에 대한 연구가 진행되고 있다. $TiCl_4$ 응집제는 인 제거에 효과적으로 적용할 수 있으며 수중에 잔류이온을 유발하지 않으며 Ti이온은 치과임플란트나 의료장비로 사용될 만큼 인체에 무해하다고 알려져 있다. 응집제 사용에 따라 생성된 응집슬러지의 처리방안에 있어서 기존 응집제의 경우 생성된 슬러지의 대부분은 하수슬러지 위탁처리업체를 통해 소각 및 매립, 재활용 되고 있으나, $TiCl_4$를 응집제로 사용할 경우 생성된 슬러지를 인발하여 건조 및 소성을 통해 이산화티타늄으로 재활용할 수 있어 슬러지를 친환경적으로 처리가 가능해 기존 슬러지 처리방안의 경제적, 환경적 부담을 줄일 수 있는 장점이 있다. 따라서 본 연구에서는 $TiCl_4$를 하수처리장 방류수에 주입하여 수중의 총인(T-P)을 처리한 후 생성된 슬러지를 인발하여 건조와 소성과정을 거쳐 이산화티타늄을 제조하였다. 방류수를 취수해 2.5mg/L의 초기 총인 농도를 가진 원수를 제조하였으며 제조된 원수에 $TiCl_4$를 0.6mL 주입하였을 때 99.93%의 총인제거효율을 얻을 수 있었다. 응집 실험 후 생성된 슬러지를 인발하여 건조 후 $300{\sim}1000^{\circ}C$의 각각 다른 온도조건에서 소성하여 이산화티타늄을 제조하였으며, SEM과 XRD를 통해 제조된 이산화티타늄의 표면특성과 결정성 분석을 실시하였다. 제조된 이산화티타늄은 $500{\sim}800^{\circ}C$에서는 아나타제, $900{\sim}1000^{\circ}C$에서는 루타일 결정구조가 나타났다. 또한, $TiCl_4$ 주입량에 따른 이산화티타늄의 최종 생산량과 제조 시 사용되는 건조로 및 소성로의 경제적 비용 등을 고려하여 이산화티타늄 1Ton을 제조하기 위해 필요한 단가를 산출하였다. 본 연구에서 제조된 이산화티타늄 1kg의 생산단가는 약 5,400원으로 나타났으며, 가장 많이 사용되는 P-25 광촉매 보다 저렴한 가격으로 제조 및 판매를 기대할 수 있다. 따라서 하수처리장에 적용 시 기존 응집제 보다 비싼 $TiCl_4$ 비용을 보완하고 친환경적인 슬러지 처리로 제조된 이산화티타늄의 유통 및 현장적용을 통해 경제적, 환경적으로 우수하다고 판단된다.

• Journal of Ginseng Research
• /
• v.19 no.2
• /
• pp.93-100
• /
• 1995

This study was undertaken to determine whether administration of a standardized gindeng extract at 300 mg.$d^1$ for 8 weeks could enhance maximum aerobic and anaerobic exercise capabilities and whether any changes of such effects can be occurred when exercise training was added. Forty-one male university students were randomly divided into four groups as ginseng-untrained (GU, n=10), ginseng-trained (GT, n=10), placebo-untrained (PU, n=10), and placebo-trained (PT, n=11). The trained groups underwent 8 weeks of aerobic exercise at 65% of individual's maximum oxygen consumption ($Vo_2$ max) for 30 min.$d^1$, 3d.$wk^1$. Prior to and at the end of experiment, $Vo_2$ max, anaerobic power (AP), anaerobic capacity (AC), and leg muscle strength were determined and some physiological parameters related to $Vo_2$ max were measured. Initially, all subject groups did not differ in average $Vo_2$ max (range 45.9 to 47.9 ml/.kg-1.min-1). After 8 weeks, the $Vo_2$ max increased significantly from the initial level by 12.6% in group GU, 14.5% in group PT, and 24.5% in group GU which was significantly higher than group GU but not group PT. Changes in all measured parameters related to $Vo_2$ max were similar among the subject groups except group PU. Both the AP and the AC were significantly increased in all subject groups (range +3.6 to +13.1% above initial for the AP and +4.4 to) 8.955 above initial for the AC) but the higher changes were found for the AP in groups PT and GU, and for the AC in grouts PT, when compared with group PU. No significant differences in the two anaerobic variables were observed between group GT and the other groups of subjects. Leg strength was also significantly enhanced over group PU in groups PT, GU and GT. There were no significant differences among the latter three subject groups. As a result of these findings, it was concluded that under the conditions of this study ginseng administration at the prescribed dose exhibited the training-like effects on $Vo_2$ max as well as anaerobic power and leg muscle strength but no clear synergistic action on these physical fitness variables occurred when both g inseng administration and exercise training were combined.

• Biomolecules & Therapeutics
• /
• v.27 no.3
• /
• pp.327-335
• /
• 2019

As the elderly population is increasing, Alzheimer's disease (AD) has become a global issue and many clinical trials have been conducted to evaluate treatments for AD. As these clinical trials have been conducted and have failed, the development of new theraphies for AD with fewer adverse effects remains a challenge. In this study, we examined the effects of Theracurmin on cognitive decline using 5XFAD mice, an AD mouse model. Theracurmin is more bioavailable form of curcumin, generated with submicron colloidal dispersion. Mice were treated with Theracurmin (100, 300 and 1,000 mg/kg) for 12 weeks and were subjected to the novel object recognition test and the Barnes maze test. Theracurmin-treated mice showed significant amelioration in recognition and spatial memories compared those of the vehicle-treated controls. In addition, the antioxidant activities of Theracurmin were investigated by measuring the superoxide dismutase (SOD) activity, malondialdehyde (MDA) and glutathione (GSH) levels. The increased MDA level and decreased SOD and GSH levels in the vehicle-treated 5XFAD mice were significantly reversed by the administration of Theracurmin. Moreover, we observed that Theracurmin administration elevated the expression levels of synaptic components, including synaptophysin and post synaptic density protein 95, and decreased the expression levels of ionized calcium-binding adapter molecule 1 (Iba-1), a marker of activated microglia. These results suggest that Theracurmin ameliorates cognitive function by increasing the expression of synaptic components and by preventing neuronal cell damage from oxidative stress or from the activation of microglia. Thus, Theracurmin would be useful for treating the cognitive dysfunctions observed in AD.

• Korean Journal of Pharmacognosy
• /
• v.50 no.1
• /
• pp.37-45
• /
• 2019

Portulaca oleracea L. (PL) has been used in traditional medicine herb for treatment of various diseases, such as diarrhea, dysentery, and skin inflammation. Previous studies have shown that the PL regulates the inflammation by inhibition of pro-inflammatory cytokines. Although PL might have improvement effects of intestinal function and bioactive effects, there are not enough studies to demonstrate. This study investigated the effects of KDC16-2 on the improvement of intestinal function and anti-inflammatory effects in vivo and in vitro. The improvement effect of intestinal function was measured fecal amount, water content and intestinal transit rate in KDC16-2 treated ICR mice. As results, compared with the control group, the KDC16-2 group showed a significant increase in wet fecal weight, dry fecal weight and fecal water content. The intestinal transit rate of KDC16-2 group was significantly increased. Based on the results, KDC16-2 is considered to have effects on improving intestinal function. The effect of anti-inflammatory demonstrated by using dextran sulfate sodium (DSS)-induced colitis mice. The mice were administered 3% DSS along with KDC16-2 (100, 300 mg/kg) for 14 days. DSS-induced colitis mice were significantly ameliorated in KDC16-2 treated group, including body weight loss, colon length shortening, tight junction protein of colon and histological colon injury. The levels of inflammatory mediators (IgG2a, IgA, C-reactive protein and Myeloperoxidase) and pro-inflammatory cytokines (tumor necrosis factor (TNF)-${\alpha}$, Interleukin (IL)-6) which are involved in inflammatory responses were increased in the DSS-treated group as compared to those in the control group, and the levels were significantly decreased in the KDC16-2 groups. In addition, we investigated the impact of KDC16-2 on lipopolysaccharide (LPS)-induced inflammatory responses in J774A.1 cells. KDC16-2 inhibited production of prostaglandin E2 (PGE2) and reactive oxygen species (ROS). These results suggested that the KDC16-2 could effectively alleviate the dysfunction of intestinal and inflammatory mediators. Thus, these KDC16-2 can be potentially used as health functional food of intestinal.

• Journal of Nutrition and Health
• /
• v.54 no.6
• /
• pp.594-602
• /
• 2021

Purpose: The zinc transporter ZIP7 is known to regulate glucose metabolism in skeletal muscles, and skeletal muscles are known to play a critical role in glycemic control. The present study examines the effects of dietary zinc supplementation on the blood glucose concentration and expression of ZIP7 in skeletal muscle obtained from obese mice fed a high-fat diet (HF). Methods: C57BL/6J male mice were divided into three groups and were administered either a HF (60% of total calories from fat), HF supplemented with zinc (HF+Zn, 60% calories from fat + 300 mg zinc/kg diet), or low-fat diet (CON, 10% calories from fat), for 15 weeks. Results: Compared to CON group mice, the final body weights and adipose tissue weights were significantly increased, while the skeletal muscle weights were significantly decreased in mice belonging to the HF and HF+Zn groups. The HF+Zn group had significantly lower levels of fasting blood glucose concentrations than the HF group. Similarly, zinc supplementation significantly decreased the HF-elevated area under the curve values obtained from the oral glucose tolerance test. Skeletal muscle protein levels of ZIP7 in samples obtained from the HF group were significantly decreased as compared to the CON group. Conversely, the skeletal ZIP7 protein levels in the HF+Zn group were significantly increased as compared to the HF group. Moreover, the protein levels of phosphorylated-AKT and glucose transporter 4 in the skeletal muscle were significantly increased subsequent to zinc supplementation. Conclusion: Our data demonstrates that zinc supplementation up-regulates the skeletal muscle ZIP7 expression, which is associated with improved glucose tolerance in the obesity.

• The Korea Journal of Herbology
• /
• v.27 no.6
• /
• pp.71-76
• /
• 2012

Objectives : The purpose of this study was to evaluate the neuroprotective effect of Pueraria lobata extract on focal cerebral ischemia in mice. Methods : Focal cerebral ischemia was induced by occlusion of the right middle cerebral artery using the intraluminal filament model. ICR male mice underwent 90 minutes of middle cerebral artery occlusion (MCAo) followed by 24 hours of reperfusion. Mice were administered Pueraria lobata extract orally at the dose of 300mg/kg just prior to reperfusion. Rotarod test and balance beam test were practiced to assess sensory-motor function 23 hours after MCAo. In rotarod test, the latency to fall on the accelerating rotarod was recorded for 5 min. In balance beam test, the score was graded according to number of slips and latency to cross. The infarct volume was measured 24 hours after MCAo using 2% 2,3,5-triphenyltetrazolium chloride (TTC) staining. Results : Pueraria lobata extract treated group showed significant reduction in infarct volume by 27.3% compared to control group (p<0.05). In rotatod test, it also showed significant extension of latency time compared to control group ($67.82{\pm}15.08$ vs. $5.62{\pm}1.06$, p<0.001). In contrast to performance in rotarod test, that in balance beam test did not improve with Pueraria lobata extract treatment. Conclusions : We conclude that Pueraria lobata extract has a significant neuroprotective effect and reduces damage of sensory-motor function in MCAo model. These findings suggest that Pueraria lobata could be a potent neuroprotective agent.